Description
Strategies involving mesenchymal stem cell (MSC) osteogenic differentiation have emerged as promising tools in regenerative medicine. These work by either promoting in situ regeneration, or through newly-fabricated tissue grafts, potentially overcoming clinical complications related to more conventional therapies. However, bioengineered bone tissue and cells do not yet achieve the required characteristics for optimal in vivo bone repair, resulting in weak or inadequate new tissue and/or biocompatibility issues. It is, therefore, crucial to further understand the differentiation of MSCs, to optimize their osteogenic commitment. The use of metabolites in this context was recently recognized, as some appear to have the potential to induce osteogenesis, while also ensuring the lack of (or residual) co-differentiation into other lineages; i.e. they can be both potent and specific. This project aims to optimize a bioreactor to drive osteogenic differentiation of human adipose MSCs (hAMSC) while allowing us to survey the cell metabolome. Based on detailed metabolomic screens, we will identify and exploit osteoinductive metabolites that will ensure the predominance of osteoblast-like cells, removing the need for use of osteogenic factors that can drive off-target , unwanted differentiation, such as dexamethasome. There is existing knowledge on the endo- and exometabolome adaptations of hAMSCs in 2D cultures and this has provided information on metabolic adaptations of osteogenesis and unveiled a set of preliminary osteoinductive metabolic candidates. The focus of this project is the translation of these approaches to 3D cultures, using an innovative encapsulation method to support hAMSC mono- or co-cultures (with endothelial cells, known to provide osteogenic factors) alongside mechanical cues provided by our bioreactor to promote osteogenesis. This non-chemical osteogenic differentiation protocol will allow detailed metabolomic analysis of the time-dependent intra- (endometabolome) and extracellular (exometabolome, including the secretome) and metabolite changes will help refine the previously proposed osteoinductive metabolic candidates, while unveiling new ones resulting from 3D cell-cell and cell-niche crosstalk. We will look for lead metabolites that can effectively and specifically stimulate osteogenic differentiation in 3D cultures in normal culture conditions with no co-differentiation into other lineages. The metabolic analysis thus generated will be confirmed by isotopic tracing studies and proteomics of intra- and extracellular environments including the vesicles secreted during MSC differentiation that are important for mineralization. Besides metabolomics and proteomics, synchrotron-based infrared microspectroscopy will provide sub-cellular scale information on the specific role of lipids and proteins in cell plasma membranes (and their fluidity), the cytoskeleton and the collagen extracellular matrix throughout osteogenesis, as a function of different 3D culture variables (mono-/co-cultures,absence/presence of mechanical force). To our knowledge, the combination of the above-mentioned biomechanical and analytical techniques represents an innovative approach to characterize the osteogenic differentiation of MSCs, providing a unique insight into the dynamic biochemical and cell-niche crosstalk adaptations, ultimately offering the means to optimize osteogenic lineage commitment using osteoinductive metabolite candidates. This project will culminate in the development of an optimized bioreactor (easily monitored overtime by exometabolomics), where osteogenesis can be enhanced with bioactive osteoinductive metabolites, ideally minimizing/excluding the addition of traditional osteoinductors. This will allow us to engineer high-quality bone tissue in a scientifically informed manner, to support a higher rate of success for biomedical applications.
Coordinator
Coordination
Universidade de Aveiro (UA)
Partners
Universidade de Coimbra; BIOCANT
Groups
G1 - Porous Materials and Nanosystems;
G5 - Biomimetic, Biological and Living Materials;
G6 - Virtual Materials and Artificial Intelligence;
Outputs
Global metabolomics identifies new extracellular biomarkers of nanovibration-driven mesenchymal stem cells osteodifferentiation
Daniela S.C. Bispo; Inês Graça; Jennifer H. Haggarty; Aliana Reis; Michael P. McCormick, Sara Bartlome; Mariana B. Oliveira; João F. Mano; Penelope M. Tsimbouri; Matthew J. Dalby; Ana M. GilLipid metabolic adaptations of multi-donor mesenchymal stem cells during osteodifferentiation
Daniela S.C. Bispo; Inês C.R. Graça; Catarina S.H. Jesus; João E. Rodrigues; Brian J. Goodfellow; Mariana B. Oliveira; João F. Mano; Ana M. GilExploring In Vitro Mesenchymal Stem Cell Osteodifferentiation via Vibrational Microspectroscopy: A Comprehensive Review
Daniela S. Bispo; Inês C. R. Graça; João A. Rodrigues; João T. S. Martins; Mariela M. Nolasco; Maria P. M. Marques; Helena I. S. Nogueira; João F. Mano; Mariana B. Oliveira; Paulo J. A. Ribeiro-Claro; Ana M. GilMetabolic markers detect early ostedifferentiation of mesenchymal stem cells from multiple donors
Daniela S. C. Bispo; Inês C. R. Graça; Catarina S. H. Jesus; João E. Rodrigues; Marlene C. Correia; Sabrina Atella; Iola F. Duarte; Brian J. Goodfellow; Mariana B. Oliveira; João F. Mano; Ana M. GilAdvancing Chemical-Free Bone Regeneration: The Contribution of Metabolomics to Nanokicking-Driven Osteodifferentiation
Bispo DSC, Tsimbouri PM, JH Haggarty, Graça I, Rodrigues JEA, Oliveira MB, Mano JF, Dalby MJ, Gil AMStem Cell Osteogenic Differentiation Probed by Atomic Force Microscopy-Infrared Nanospectroscopy: Sub-cellular Biochemical Characterization
Martins JTS; Nolasco MM; Rodrigues JEA; Martins CB; Graça I; Carvalho ALMB; Bispo DSC; Oliveira MB; Mano JF; Nogueira HIS; Ribeiro-Claro PJA; Marques MPM; Gil AMUncovering Donor-Dependent Exoproteome Dynamics During MSC Osteogenic Differentiation
Rodrigues JEA; Maurício T; Graça I; Bispo DSC; Oliveira MB; Mano JF; Domingues P; Gil AMExploring MSCs Donor Heterogeneity with Non-Invasive ExoMetabolomics to Find Universal Osteogenic Signatures
Bispo, DSC; Rodrigues, JA; Graça, ICR; Correia, M; Jesus, CSH; Oliveira, MB; Mano, JF; Gil, AMStem Cell Differentiation into Bone Probing Cellular Events by Vibrational Spectroscopy
Marques, MPM; Martins, CB; Carvalho, ALMB; Nolasco, MN; Rodrigues, JA; Bispo, DSC; Nogueira, HIS; Ribeiro-Claro, PJA;, Oliveira, MB; Mano, JF; Gil, AMNon-invasive detection of universal osteodifferentiation signatures through untargeted NMR Exometabolomics
Bispo, DSC; Rodrigues, JA; Oliveira, MB; Mano, JF; Gil, AMPioneering Vibrational Spectroscopy to Monitor the Osteodifferentiation of Mesenchymal Stem Cells
Mariela M. Nolasco, João A. Rodrigues, Clara B. Martins, Ana L.M. Batista de Carvalho, Daniela S. C. Bispo, Helena I.S. Nogueira, Paulo J.A. Ribeiro-Claro, Mariana B. Oliveira, João F. Mano, Maria P.M. Marques, Ana M. GilUnveiling MSCs osteodifferentiation patterns across don ors through non-invasive NMR metabolomics
Daniela S.C. Bispo, Marlene Correia, Joao A. Rodrigues, Mariana B. Oliveira, Joao F. Mano, Ana M. GilMetabolites Report on Early Stem Cell Osteodifferentiation: New Markers for Effective Bone Regeneration
Daniela S.C. Bispo, João A. Rodrigues, Inês Graça, Catarina S.H. Jesus, Marlene Correia, Iola F. Duarte, Brian J. Goodfellow, Mariana B. Oliveira, João F. Mano, Ana M. GilImpact of Conventional and Potential New Metal-Based Drugs on Lipid Metabolism in Osteosarcoma MG-63 Cells
Bispo, DSC; Correia, M; Carneiro, TJ; Martins, AS; Reis, AAN; de Carvalho, ALMB; Marques, MPM; Gil, AMNon-invasive monitoring of mesenchymal stem cells osteodifferentiation by untargeted NMR exometabolomics
Bispo, DSC; Correia, M; Jesus, CSH; Oliveira, MB; Mano, JF; Gil, AMSearching for donor-independent metabolic markers by NMR metabolomics
Gil, AM; Bispo, DSC; Correia, M; Jesus, CSH; Mano, JF; Oliveira, MBUnveiling early predictive markers of mesenchymal stem cells osteodifferentiation capacity through NMR metabolomics
Correia MC, Bispo DSC, Jesus CSH, Rodrigues JEA, Oliveira MB, Mano JF, Gil AMSponsors

